Follow the Money to Medical Devices & Diagnostics
Spotlight on Ivantis, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities.
Ivantis is a U.S. private company that develops solutions for the treatment of glaucoma. It raised $25 million in a completion of a Series C venture capital investment as reported in the PharmSource Lead Sheet on January 12, 2017.
- Ivantis was founded in 2007
- Corporate Headquarters: Irvine, CA
- Ivantis plans to use the proceeds to support US approval and commercialization efforts for the Hydrus Microstent.
Device: Hydrus Microstent™
Development Phase: Pivotal Studies
Medical Specialty: Ophthalmology
Purpose: Device – Therapeutic/Interventional
Type: Implant – Stent
Description: A nitinol microstent designed to relieve high intraocular pressure, commonly caused by primary open angle glaucoma.
US – PMA planned
EU – CE Mark approval
Australia – TGA approval
- September 2014: $25 million in a completed venture capital investment
- January 2014: $14 million in a completed venture capital investment
- August 2013: $5 million in a completed venture capital investment
- February 2013: $27 million in a completed venture capital investment
Medical Device & Diagnostics Pipeline1
|Product Candidate||Indication||Medical Specialty||Purpose||Type||Status|
|Hydrus Microstent||Glaucoma||Ophthalmology||Device – Therapeutic/Interventional||Implant – Stent||Pivotal Studies|
Regulatory Approvals and Clearances
|Product Candidate||Region||Approval/Clearance||Year of Approval or Clearance|
|Hydrus Microstent||EU||CE Mark||2011|
1Source: PharmSource Lead Sheet
|Ivantis, Inc.||Key Officers|
|38 Discovery, Suite 150||Dave Van Meter, President & CEO|
|Irvine, CA 92618 USA||Brett Trauthen, CSO|
|Phone: +1-949-600-9650||Ken Galt, VP, R&D|
|Fax: +1-949-600-9651||Gretchen Haig, Director, Clinical Research|
|Web: www.ivantisinc.com||Gary Krasner, Senior Clinical Project Manager|
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Femasys, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Genalyte Inc.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Bigfoot Biomedical